Established in 1982, the principal activity of Randox is the design, manufacture and marketing of a vast range of high-quality products for laboratory medicine. Randox ranks in 20th position within the global clinical diagnostics market. Randox’s extensive product portfolio includes clinical chemistry reagents and analysers, quality control material, internal quality control software, RIQAS – the largest global External Quality Assurance scheme in the world - and Biochip Array Technology (BAT) that allows simultaneous detection of multiple analytes using a single patient sample for a complete patient profile and effective diagnosis. Randox won the McRobert Award for Engineering for BAT and has five Queen’s Awards for Export. Randox products are used in over 145 countries worldwide by hospital laboratories, veterinary clinics/laboratories, pharmaceutical/CRO companies, forensic laboratories and food and wine testing laboratories. Randox are committed to ensuring individuals worldwide have access to timely and correct diagnosis.